Fly News Breaks for October 27, 2016
CSII
Oct 27, 2016 | 07:51 EDT
Following three "solid" quarters in a row of stable-to-improving growth and a new CEO in place, Leerink analyst Danielle Antalffy says Cardiovascular Systems has reached a fundamental inflection point after several quarters of underperformance in light of sales force disruptions and poor execution and is well on track to deliver sustainable double-digit top-line growth going forward. The analyst reiterates an Outperform rating and $30 price target on the shares.
News For CSII From the Last 2 Days
There are no results for your query CSII